Abstract Effector T cells equipped with engineered antigen receptors specific for cancer targets have proven to be very efficient. Two methods have emerged: the Chimeric Antigen Receptors (CARs) and T-cell Receptor (TCR) redirection. Although very potent. CAR recognition is limited to membrane antigens which represent around 1% of the total proteins expressed. https://oznicoes.shop/product-category/w-bags/